1. Home
  2. ALV vs RDY Comparison

ALV vs RDY Comparison

Compare ALV & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autoliv Inc.

ALV

Autoliv Inc.

HOLD

Current Price

$120.69

Market Cap

9.7B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.95

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALV
RDY
Founded
1953
1984
Country
Sweden
India
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
11.6B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
ALV
RDY
Price
$120.69
$13.95
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$133.45
$16.90
AVG Volume (30 Days)
586.1K
1.2M
Earning Date
01-30-2026
01-22-2026
Dividend Yield
2.83%
0.51%
EPS Growth
25.57
9.95
EPS
9.69
0.79
Revenue
$10,614,000,000.00
$3,851,623,984.00
Revenue This Year
$4.73
$6.16
Revenue Next Year
$4.40
$2.57
P/E Ratio
$12.40
$17.89
Revenue Growth
0.85
14.10
52 Week Low
$75.49
$12.26
52 Week High
$129.54
$16.17

Technical Indicators

Market Signals
Indicator
ALV
RDY
Relative Strength Index (RSI) 54.24 49.65
Support Level $118.76 $13.90
Resistance Level $122.90 $14.16
Average True Range (ATR) 2.31 0.15
MACD 0.33 -0.00
Stochastic Oscillator 67.32 56.64

Price Performance

Historical Comparison
ALV
RDY

About ALV Autoliv Inc.

Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: